Serum bilirubin predicts long-term clinical outcomes in patients with cardiac syndrome X

Heart
Shao-Sung HuangJaw-Wen Chen

Abstract

Increased oxidative stress and vascular inflammation have been demonstrated in patients with cardiac syndrome X (CSX). Bilirubin, once considered simply the metabolic end product of haem degradation, has emerged as a potential endogenous inhibitor of atherosclerosis. This study was conducted to evaluate the prognostic role of serum bilirubin in disease progression and clinical outcome in patients with CSX. A total of 108 consecutive CSX patients were enrolled. Serum bilirubin levels were examined from blood samples collected before coronary angiography. All patients were prospectively followed up for 5 years for the composite end point of total adverse events including death and non-fatal cardiovascular events (non-fatal myocardial infarction, ischaemic stroke, rehospitalisation for unstable angina, and coronary revascularisation). There were 20 adverse events, including five deaths, five ischaemic strokes and 10 rehospitalisations for unstable angina during follow-up. Patients with adverse events had lower baseline serum bilirubin levels (p<0.001). All patients were stratified into high-bilirubin, normal-bilirubin and low-bilirubin groups. The patients in the high-bilirubin group had the lowest incidence of total adverse event...Continue Reading

Citations

Mar 19, 2014·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Amir A MahabadiGerd Heusch
Jan 7, 2014·Journal of Critical Care·Mehmet GulHuseyin Uyarel
Jun 16, 2011·Journal of Women's Health·Kyung-Min KwonHee-Taik Kang
Sep 17, 2013·Journal of Diabetes·Syeda Sadia NajamGuang Ning
Apr 26, 2011·Clinical Biochemistry·Shao-Sung HuangShing-Jong Lin
Sep 29, 2015·Diabetology & Metabolic Syndrome·Kae-Woei LiangWayne H-H Sheu
Aug 26, 2014·PPAR Research·Cyril BigoOlivier Barbier
Apr 12, 2014·Annals of Medicine·Seung Joo KangPeter Kruzliak
Oct 17, 2012·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Ying-Chieh LiaoWayne H-H Sheu
Dec 25, 2017·Journal of the American Heart Association·Tsung-Lin YangMai-Szu Wu
Jan 10, 2020·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Kae-Woei LiangWayne H-H Sheu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.